Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (BMC Cancer, (2024), 24, 1, (16), 10.1186/s12885-023-11783-5)

Basit Öğe Kaydı
dc.authorid0000-0003-2538-8569
dc.contributor.authorŞenocak Taşçı, Elif
dc.contributor.authorOyan, Başak
dc.contributor.authorSönmez, Özlem
dc.contributor.authorMutlu, Arda Ulaş
dc.contributor.authorAtcı, Muhammed Mustafa
dc.contributor.authorSakin, Abdullah
dc.contributor.authorÖner, İrem
dc.contributor.authorYeşil Çınkır, Havva
dc.contributor.authorKarakurt Eryılmaz, Melek
dc.contributor.authorÇağlayan, Dilek
dc.contributor.authorYazdan Balçık, Onur
dc.contributor.authorPaksoy, Nail
dc.contributor.authorBozkurt, Mustafa
dc.date.accessioned2024-02-02T08:42:26Z
dc.date.available2024-02-02T08:42:26Z
dc.date.issued2024
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractFollowing publication of the original article [1], the authors reported an error in the affiliations of authors Başak Oyan, Özlem Sönmez, Leyla Özer, Ali Arıcan, Özlem Er and Mustafa Bozkurt. These authors are all affiliated to institution 2.
dc.identifier.citationŞenocak Taşçı, E., Oyan, B., Sönmez, Ö., Mutlu, A. U., Atcı, M. M., Sakin, A. ... Bozkurt, M. (2024). Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (BMC Cancer, (2024), 24, 1, (16), 10.1186/s12885-023-11783-5). BMC Cancer, 24(1). https://dx.doi.org/10.1186/s12885-024-11863-0
dc.identifier.doi10.1186/s12885-024-11863-0
dc.identifier.issn1471-2407
dc.identifier.issue1
dc.identifier.pmid38166764
dc.identifier.scopus2-s2.0-85182828807
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://dx.doi.org/10.1186/s12885-024-11863-0
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12240
dc.identifier.volume24
dc.indekslendigikaynakScopus
dc.institutionauthorSakin, Abdullah
dc.language.isoen
dc.publisherBioMed Central Ltd
dc.relation.ispartofBMC Canceren_US
dc.relation.publicationcategoryDiğer
dc.rightsAttribution 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectColon Cancer
dc.subjectFluouracil
dc.subjectRechallenge
dc.subjectRegorafenib
dc.subjectSurvival
dc.subjectThird-Line Treatment
dc.titleCorrection: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (BMC Cancer, (2024), 24, 1, (16), 10.1186/s12885-023-11783-5)
dc.typeOther

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Sakiin-Abdullah-2024.pdf
Boyut:
653.29 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Diğer Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu